Consistent with several studies showing a favorable effect of pan-PPAR agonism on liver steatosis, inflammation, and fibrosis in mouse and rat models,22,24,43,44 lanifibranor decreased the expression of various fibrosis-related proteins in the livers of Lal−/− mice. The gene discussed is PPARA; the disease is fatty liver disease.